Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori

Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency

(2018) David Y. Graham et al.   Clinical Gastroenterology and Hepatology

Update on the Use of Vonoprazan: A Competitive Acid Blocker

(2018) David Y. Graham et al.   GASTROENTEROLOGY

Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases

(2018) Tadayuki Oshima et al.   Journal of Neurogastroenterology and Motility

Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori : A multicenter, prospective, randomized trial

(2017) Soichiro Sue et al.   HELICOBACTER

Review: A Japanese population-based meta-analysis of vonoprazan versus PPI for Helicobacter pylori eradication therapy: Is superiority an illusion?

(2017) Shou Quan Dong et al.   HELICOBACTER

The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication

(2017) Soichiro Sue et al.   INTERNAL MEDICINE

World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat

(2017) Hidekazu Suzuki et al.   JOURNAL OF GASTROENTEROLOGY

Helicobacter pylori infection and antibiotic resistance: a WHO high priority?

(2017) Bich N. Dang et al.   Nature Reviews Gastroenterology & Hepatology

Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori

(2017) Teppei Adachi et al.   ONCOLOGY

Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype

(2016) T. Kagami et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance

(2016) Hiroshi Matsumoto et al.   DIGESTIVE DISEASES AND SCIENCES

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a phase III, randomised, double-blind study

(2016) Kazunari Murakami et al.   GUT

Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report

(2016) P Malfertheiner et al.   GUT

Evidence-based clinical practice guidelines for peptic ulcer disease 2015

(2016) Kiichi Satoh et al.   JOURNAL OF GASTROENTEROLOGY

Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases

(2016) Nobuhiro Inatomi et al.   PHARMACOLOGY & THERAPEUTICS

Letter: promising results ofHelicobacter pylorieradication with vonoprazan-based triple therapy after failure of proton pump inhibitor-based triple therapy

(2015) T. Inaba et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Kyoto global consensus report onHelicobacter pylorigastritis

(2015) Kentaro Sugano et al.   GUT

Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan

(2013) Kazunari Murakami et al.   JOURNAL OF GASTROENTEROLOGY

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

(2012) Catherine de Martel et al.   LANCET ONCOLOGY

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Helicobacter pylori treatment in the era of increasing antibiotic resistance

(2010) D. Y. Graham et al.   GUT

Guidelines for the Management ofHelicobacter pyloriInfection in Japan: 2009 Revised Edition

(2010) Masahiro Asaka et al.   HELICOBACTER

Helicobacter pyloriInfection

(2010) Kenneth E.L. McColl   NEW ENGLAND JOURNAL OF MEDICINE

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

(2009) Alessandro Liberati et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Epidemiology ofHelicobacter pyloriinfection and gastric cancer in Asia

(2009) Kwong Ming Fock et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY